Arcutis Biotherapeutics Inc

ARQT USD0.0001
Create an alert
Sell$23.88
Buy$23.89
$0.24 (1.01%)
Last updated today at
Back to dashboard

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
27 August 2026
Terrie CurranDirector
Sell
Option/Award related
27,052$25.03$677,095.3323,526
27 August 2026
Terrie CurranDirector
Sell
Option/Award related
11,148$25.03$279,027.7523,526
20 August 2026
Terrie CurranDirector
Sell
Option/Award related
1,072$26.04$27,912.3123,526
19 August 2026
Patrick BurnettOther Level A
Sell
Tax related
1,697$27.00$45,819.00117,592
17 August 2026
Howard G WelgusDirector
Sell
Regular sell transaction (market)
4,730$26.18$123,834.7136,475
12 August 2026
Patrick BurnettOther Level A
Sell
Option/Award related
6,700$26.08$174,767.49119,289
11 August 2026
Patrick BurnettOther Level A
Sell
Option/Award related
8,300$26.52$220,129.28119,289
3 August 2026
Todd Franklin WatanabePresident/CEO
Sell
Tax related
4,375$26.12$114,261.00717,203
3 August 2026
Masaru (Mas) MatsudaChief Legal/Compliance Officer
Sell
Tax related
1,230$26.12$32,123.66126,171
3 August 2026
Patrick BurnettOther Level A
Sell
Tax related
955$26.12$24,941.54119,289

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
24 November 2025
Todd Franklin WatanabePresident/CEO
Sell
Regular sell transaction (market)
48,945$30.36$1,485,754.84740,537
28 October 2025
Todd Franklin WatanabePresident/CEO
Sell
Regular sell transaction (market)
40,000$25.03$1,001,032.00806,440
2 March 2026
Todd Franklin WatanabePresident/CEO
Sell
Tax related
36,281$25.16$912,851.73787,025
13 November 2025
Neha KrishnamohanDirector
Sell
Option/Award related
39,272$23.19$910,701.9723,355
24 November 2025
Sue-Jean LinDirector
Sell
Option/Award related
25,272$30.78$777,955.5626,735

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.